2Gatzemeier U,Shepherd F A,Le Chevalier T,et al.Activity of gamcitabine in patients with non-small cell lung cancer;a multicentre,extended phase II study[J].Eur J Cancer,1996,32A(2):243-248.
3Ricci S,Autonuzzo A,Galli L,et al.Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer;a multicenter phase II study[J].Lung Cancer,2000,27(2):75-80.
4Johnson D H.Gemcitabin for the treatment of non-small sell lung cancer[J].Oncol(Huntington),2001,15(supp17):17.
6Cardenal F,Lopez Cabrerizo M P,Anton A,et al.Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer[J].J Clin Oncol,1999,17(1):12-18.
9胡文青,刘丽辉.阿米福汀在血液系统疾病中的应用[J].Journal of Clinica Hematology,2009,22(9):508-511.
10Souid A K,Newton G L,Dubowy R L,et,al.Determination Of the cytoprotective agent WR-2721(amifostine,Ethyol)and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography[J].Cancer Chemo Ther Pharmacol,1998,42:400.
5Patrick Therasse, Susan G. Arbuck, et al. New guidelines to evaluate the response to treatment in solid tumors. Bull Cancer, 2000, 87:881 - 886.
6孙燕,周际昌.临床肿瘤内科学.第4版.北京:人民卫生出版,2003,586-587.
7Asai G, Fukuoka M. Phase lI studies of gemestabine for non-small cell lung cancer in Japan. Gala To Kagaku Rvoho, 1999, 26(7) : 884.
8Rou A Bun J. Triplet chemotherapy with gemcitabine , a platinum and a third agent in the treatment of advanced non-small cell lung cancer. Semin Oncol, 1999,26( 1 ) :25 - 30.
9Nevmark N, Lianes P, Smit EF, et al. Economic evaluationof three two-drug chemotherapy regimens in advancednon-small-cell lung cancer. Pharmacoeconomics, 2005,23 ( 11 ) : 1155 - 1166.
10Schiler J H, Harrington D, Sandler A, et al. A randomized phase Ⅰ - Ⅱ trial of four chemotherapeutic regiments in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol,2000,19(2) :10.
